Related Experiment Video

Updated: Jun 25, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy

Maria Quanz1, Nathalie Berthault, Christophe Roulin

  • 1Institut Curie, Centre de Recherche, Orsay, France.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|February 5, 2009
PubMed
Abstract

Insights

Novel DNA molecules (Dbait) mimic DNA damage, inhibiting repair and sensitizing radioresistant tumors to radiation therapy. This strategy enhances radiotherapy effectiveness against difficult-to-treat cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy Research

Background:

  • Tumor resistance to radiotherapy is often linked to enhanced DNA repair mechanisms.
  • Targeting DNA repair pathways presents a potential strategy to overcome radioresistance.

Purpose of the Study:

  • To investigate the hypothesis that inhibiting DNA damage repair can sensitize tumors to radiotherapy.
  • To evaluate a novel strategy using DNA molecules that mimic DNA double-strand breaks (Dbait) to disrupt DNA repair signaling.

Main Methods:

  • Designed and synthesized small DNA molecules (Dbait) to mimic DNA double-strand breaks.
  • Assessed Dbait effects on DNA repair foci formation (H2AX phosphorylation, NBS1, 53BP1) in cultured cells and xenografted tumors.
  • Evaluated Dbait efficacy alone and in combination with fractionated radiotherapy in radioresistant tumor models.

Main Results:

  • Dbait molecules induced H2AX phosphorylation, indicating activation of DNA damage signaling.
  • Dbait treatment inhibited the formation of DNA repair foci and sensitized cells to irradiation.
  • In vivo, Dbait promoted regression of radioresistant head and neck squamous cell carcinoma and melanoma xenografts.
  • Combination therapy with Dbait and radiotherapy significantly improved tumor growth control.

Conclusions:

  • The study validates the concept of using DNA-mimicking molecules to trigger false DNA damage signals and inhibit repair.
  • This novel strategy holds promise for enhancing radiotherapy efficacy in radioresistant tumors.

More Related Videos

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays05:01

Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays

Published on: June 14, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...